RNA interference has broad therapeutic potential due to its high specificity and ability to potentially evade drug resistance. Three cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes derived from polymer axles of different sizes (MW 2,000, 3,400, and 10,000) have been synthesized for delivering siRNA. These polyrotaxanes are able to condense siRNA into positively charged particles that are <200 nm in diameter, enabling their facile internalization into mammalian cells. The cationic polyrotaxanes display cytotoxicity profiles that are >10(2)-fold lower than the commercial standard bPEI and gene silencing efficiencies that are comparable to those of both Lipofectamine 2000 and bPEI. Our findings suggest that the cationic polyrotaxanes display a size-activity relationship, wherein the higher molecular weight polyrotaxanes (PEG3,400 and 10,000) are able to condense and deliver siRNA better than the lower molecular weight material (PEG2,000).
RNA interference has broad therapeutic potential due to its high specificity anpan>d ability to potentially evade drug resistanpan>ce. Three cationpan>ic α-pan> class="Chemical">cyclodextrin:poly(ethylene glycol) polyrotaxanes derived from polymer axles of different sizes (MW 2,000, 3,400, and 10,000) have been synthesized for delivering siRNA. These polyrotaxanes are able to condense siRNA into positively charged particles that are <200 nm in diameter, enabling their facile internalization into mammalian cells. The cationic polyrotaxanes display cytotoxicityprofiles that are >10(2)-fold lower than the commercial standard bPEI and gene silencing efficiencies that are comparable to those of both Lipofectamine 2000 and bPEI. Our findings suggest that the cationic polyrotaxanes display a size-activity relationship, wherein the higher molecular weight polyrotaxanes (PEG3,400 and 10,000) are able to condense and deliver siRNA better than the lower molecular weight material (PEG2,000).
Authors: Aditya Kulkarni; Vivek Badwaik; Kyle DeFrees; Ryan A Schuldt; Dinara S Gunasekera; Cory Powers; Alexander Vlahu; Ross VerHeul; David H Thompson Journal: Biomacromolecules Date: 2013-12-02 Impact factor: 6.988
Authors: Vivek D Badwaik; Emilio Aicart; Yawo A Mondjinou; Merrell A Johnson; Valorie D Bowman; David H Thompson Journal: Biomaterials Date: 2016-01-08 Impact factor: 12.479
Authors: Amanda Acevedo-Jake; Andrew T Ball; Marzia Galli; Mikiembo Kukwikila; Mathieu Denis; Daniel G Singleton; Ali Tavassoli; Stephen M Goldup Journal: J Am Chem Soc Date: 2020-03-20 Impact factor: 15.419